Special Issues
Unmet Needs of Individuals Living with Higher-Risk Myelodysplastic Syndromes: Perspectives from the Global Patient Advocacy Community Read More ›
Over the past 20 years, advances in the treatment of chronic myeloid leukemia (CML) have made this type of cancer highly treatable, such that most patients can live long and productive lives. Today, people diagnosed with CML who are treated with targeted medications have similar life expectancies as people without CML. Read More ›